Search research articles
Contact Us
Filters
Showing results (1-10 of 59) with videos related to
Page
of 6
Sort By:
Bladder Cancer (Amsterdam, Netherlands)
|
February 3, 2017
Ten Years of Proteomics in Bladder Cancer: Progress and Future Directions
Maria Frantzi, Antonia Vlahou
Proteomics. Clinical Applications
|
February 7, 2019
Proteomics in Drug Development: The Dawn of a New Era?
Maria Frantzi, Agnieszka Latosinska, Harald Mischak
Current Opinion in Urology
|
July 25, 2012
Biomarkers for bladder cancer aggressiveness
Maria Frantzi, Manousos Makridakis, Antonia Vlahou
Mass Spectrometry Reviews
|
June 26, 2023
Peptides as "better biomarkers"? Value, challenges, and potential solutions to facilitate implementation
Agnieszka Latosinska, Maria Frantzi, Justyna Siwy
Proteomics. Clinical Applications
|
February 16, 2019
Clinical Proteomics on the Path Toward Implementation: First Promises Delivered
Maria Frantzi, Harald Mischak, Agnieszka Latosinska
Clinical and Translational Medicine
|
April 1, 2014
Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development
Maria Frantzi, Akshay Bhat, Agnieszka Latosinska
Expert Review of Molecular Diagnostics
|
March 6, 2023
Statistical determination of cancer biomarkers: moving forward clinically
Marika Mokou, Harald Mischak, Maria Frantzi
Expert Review of Proteomics
|
December 16, 2025
Identifying biomarkers at an early stage: overcoming limitations of clinical proteomics
Agnieszka Latosinska, Maria Frantzi, Justyna Siwy, et al.
Expert Review of Proteomics
|
November 10, 2018
Urinary proteomic biomarkers in oncology: ready for implementation?
Maria Frantzi, Agnieszka Latosinska, Iwona Belczacka, et al.
Proteomics
|
May 23, 2018
Clinical Proteomics: Closing the Gap from Discovery to Implementation
Maria Frantzi, Agnieszka Latosinska, Georgia Kontostathi, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 59) with videos related to
Sort By:
Page
of 6
Bladder Cancer (Amsterdam, Netherlands)
|
February 3, 2017
Ten Years of Proteomics in Bladder Cancer: Progress and Future Directions
Maria Frantzi, Antonia Vlahou
Proteomics. Clinical Applications
|
February 7, 2019
Proteomics in Drug Development: The Dawn of a New Era?
Maria Frantzi, Agnieszka Latosinska, Harald Mischak
Current Opinion in Urology
|
July 25, 2012
Biomarkers for bladder cancer aggressiveness
Maria Frantzi, Manousos Makridakis, Antonia Vlahou
Mass Spectrometry Reviews
|
June 26, 2023
Peptides as "better biomarkers"? Value, challenges, and potential solutions to facilitate implementation
Agnieszka Latosinska, Maria Frantzi, Justyna Siwy
Proteomics. Clinical Applications
|
February 16, 2019
Clinical Proteomics on the Path Toward Implementation: First Promises Delivered
Maria Frantzi, Harald Mischak, Agnieszka Latosinska
Clinical and Translational Medicine
|
April 1, 2014
Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development
Maria Frantzi, Akshay Bhat, Agnieszka Latosinska
Expert Review of Molecular Diagnostics
|
March 6, 2023
Statistical determination of cancer biomarkers: moving forward clinically
Marika Mokou, Harald Mischak, Maria Frantzi
Expert Review of Proteomics
|
December 16, 2025
Identifying biomarkers at an early stage: overcoming limitations of clinical proteomics
Agnieszka Latosinska, Maria Frantzi, Justyna Siwy, et al.
Expert Review of Proteomics
|
November 10, 2018
Urinary proteomic biomarkers in oncology: ready for implementation?
Maria Frantzi, Agnieszka Latosinska, Iwona Belczacka, et al.
Proteomics
|
May 23, 2018
Clinical Proteomics: Closing the Gap from Discovery to Implementation
Maria Frantzi, Agnieszka Latosinska, Georgia Kontostathi, et al.
Page
of 6